For Argument sake what is the consensus on required cash msb...

For Argument sake what is the consensus on required cash msb would need?

As stated in the half yearly, the funds would be used for working capital and fund confirmatory trails.

If worst case a new RCT PH3 was needed for adult AGVHD, just how much would that cost and how long would they need to fund themselves till approval?

CHF would surely need a partner to fund the future.

S.I. did say they may go CLBP alone in the U.S.
If worst case a 2nd PH3 was required would it need to be a 2 year study? If so it may take a year to set up and recruit, 2 to study and a year to review and submit an application.

Nail biting it appears to me.

Hopefully it more then 100 million and big pharma do like what they see.